TLP
NVO

Tri Locum Partners’s Novo Nordisk NVO Stock Holding History

Tri Locum Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-209,984
Closed -$18.1M – 34
2024
Q4 		$18.1M Buy
209,984
+142,727
+212% +$15.4M 3.74% 13
2024
Q3 		$8.01M Buy
67,257
+3,446
+5% +$460K 1.92% 18
2024
Q2 		$9.11M Buy
+63,811
New +$8.46M 2.3% 18

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Tri Locum Partners's NVO Position: Q1 2025 in Review

Tri Locum Partners sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 209,984 shares — an estimated $18.1M sold.

Tri Locum Partners first reported a position in NVO in Q2 2024 and held it in 3 quarters. The position peaked at $18.1M in Q4 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Tri Locum Partners reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Tri Locum Partners sold 209,984 Novo Nordisk shares in Q1 2025, an estimated $18.1M.
  • Tri Locum Partners first reported a position in Novo Nordisk in Q2 2024 and held it in 3 quarters.
  • Tri Locum Partners's Novo Nordisk position peaked at $18.1M in Q4 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Tri Locum Partners's 13F filing for Q1 2025, filed 14 May 2025.